Skip to main content
Top
Published in: Supportive Care in Cancer 9/2017

01-09-2017 | Original Article

Mapping French people and health professionals’ positions regarding the circumstances of morphine use to relieve cancer pain

Authors: Julie Mazoyer, Maria Teresa Muñoz Sastre, Paul Clay Sorum, Etienne Mullet

Published in: Supportive Care in Cancer | Issue 9/2017

Login to get access

Abstract

Background

Cancer patients suffer in part because some health professionals prescribe or administer amounts of analgesics, namely opioids, which are too small or too widely spaced to be fully effective. Patients’ reluctance to use opioids for pain treatment is often mentioned as a reason not to apply the official guidelines, but very few studies have been conducted on people’s attitudes about opioid use to relieve cancer pain.

Methods

One hundred twenty lay participants and 30 health professionals (7 physicians and 23 nurses) were presented with a set of vignettes describing a terminally ill woman with cancer who is in pain. The vignettes were composed according to a four within-subject factor design: (a) level of pain reported by the patient, (b) patient’s explicit request for additional administration of analgesics, (c) the physicians’ final decision (e.g., to use a stronger analgesic combining paracetamol and codeine), and (d) the way the decision was made (collectively or not). Participants were asked to assess the extent to which the physician’s decision was, in their view, acceptable.

Results

Seven qualitatively different positions were found among participants. They were called as follows: tend to disagree with any decision (9%), increase the strength of the painkiller in any case (16%), give morphine preferentially (9%), partly depends on pain level (23%), fully depends on pain level (6%), depends on decision process and on pain level (22%), and tend not to disagree with any collective decision (25%).

Conclusions

Overall, 91% of participants agreed with the use of morphine in terminally ill cancer patients when the pain level was high (score of 7) and the decision to increase the strength of the painkiller was taken collectively. This percentage dropped to 69% when the team was not involved in the decision and to 40% when the pain level was lower (score of 4). If opposition to the use of morphine exists, it is not opposition to morphine itself but opposition to the circumstances of its use.
Literature
1.
go back to reference Pargeon KL, Hailey BJ (1999) Barriers to effective cancer pain management: a review of the literature. J Pain Sympt Manag 18(5):358–368CrossRef Pargeon KL, Hailey BJ (1999) Barriers to effective cancer pain management: a review of the literature. J Pain Sympt Manag 18(5):358–368CrossRef
2.
go back to reference Bauwens S, Distelmans W, Storme G, Kaufman L (2001) Attitudes and knowledge about cancer pain in Flanders. The educational effect of workshops regarding pain and symptom control. Palliat Med 15(3):181–190CrossRefPubMed Bauwens S, Distelmans W, Storme G, Kaufman L (2001) Attitudes and knowledge about cancer pain in Flanders. The educational effect of workshops regarding pain and symptom control. Palliat Med 15(3):181–190CrossRefPubMed
3.
go back to reference Jacobsen R, Sjøgren P, Møldrup C, Christrup L (2007) Physician-related barriers to cancer pain management with opioid analgesics: a systematic review. J Opioid Manag 3(4):207–214PubMed Jacobsen R, Sjøgren P, Møldrup C, Christrup L (2007) Physician-related barriers to cancer pain management with opioid analgesics: a systematic review. J Opioid Manag 3(4):207–214PubMed
4.
go back to reference Deandrea S, Montanari M, Moja L, Apolone G (2008) Prevalence of undertreatment in cancer pain: a review of published literature. Ann Oncol 19(12):1985–1991CrossRefPubMedPubMedCentral Deandrea S, Montanari M, Moja L, Apolone G (2008) Prevalence of undertreatment in cancer pain: a review of published literature. Ann Oncol 19(12):1985–1991CrossRefPubMedPubMedCentral
5.
go back to reference Bandieri E, Chirarolanza A, Luppi M, Magrini N, Marata AM, Ripamonti C (2009) Prescribtion op opioids in Italy: everything but the morphine. Ann Oncol (Letters to the editor) 20(9):961–962CrossRef Bandieri E, Chirarolanza A, Luppi M, Magrini N, Marata AM, Ripamonti C (2009) Prescribtion op opioids in Italy: everything but the morphine. Ann Oncol (Letters to the editor) 20(9):961–962CrossRef
7.
go back to reference Larue F, Colleau SM, Fontaine A, Brasseur L (1995) Oncologists and primary care physicians' attitudes toward pain control and morphine prescribing in France. Cancer 76(11):2375–2382CrossRefPubMed Larue F, Colleau SM, Fontaine A, Brasseur L (1995) Oncologists and primary care physicians' attitudes toward pain control and morphine prescribing in France. Cancer 76(11):2375–2382CrossRefPubMed
8.
go back to reference Mas C, Albaret MC, Sorum PC, Mullet E (2010) French general practitioners vary in their attitudes toward treating terminally-ill patients. Palliat Med 24(1):60–67CrossRefPubMed Mas C, Albaret MC, Sorum PC, Mullet E (2010) French general practitioners vary in their attitudes toward treating terminally-ill patients. Palliat Med 24(1):60–67CrossRefPubMed
9.
go back to reference Chou R, Fanciillo GJ, Fine PG, Adler JA, Ballantyne JC, for the American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel et al (2009) Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10(2):113–130CrossRefPubMedPubMedCentral Chou R, Fanciillo GJ, Fine PG, Adler JA, Ballantyne JC, for the American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel et al (2009) Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10(2):113–130CrossRefPubMedPubMedCentral
11.
go back to reference OPEN Minds (2005) The white paper on opioids and pain: A pan-European challenge. OPEN Minds (2005) The white paper on opioids and pain: A pan-European challenge.
12.
go back to reference World Health Organization (1996) Cancer pain relief with a guide to opioid availability. World Health Organization, Geneva World Health Organization (1996) Cancer pain relief with a guide to opioid availability. World Health Organization, Geneva
13.
go back to reference World Health Organization (2011) Ensuring balance in national policies on controlled substances. World Health Organization, Geneva World Health Organization (2011) Ensuring balance in national policies on controlled substances. World Health Organization, Geneva
14.
go back to reference Tech PJ, Camm CF (2012) NICE opioids in palliative care (clinical guideline 140)—A guideline summary. Ann Med Surg 1(1):44–48 Tech PJ, Camm CF (2012) NICE opioids in palliative care (clinical guideline 140)—A guideline summary. Ann Med Surg 1(1):44–48
15.
go back to reference Radbruch L, Junger S, Payne S, Scholten W (eds) (2014) Access to opioid medication in Europe: final report and recommendations to the ministries of health. Pallia Med Verlag, Bonn Radbruch L, Junger S, Payne S, Scholten W (eds) (2014) Access to opioid medication in Europe: final report and recommendations to the ministries of health. Pallia Med Verlag, Bonn
16.
go back to reference Larue F, Fontaine A, Brasseur L (1999) Evolution of the French public's knowledge and attitudes regarding postoperative pain. Anesth Analg 89(3):659–664CrossRefPubMed Larue F, Fontaine A, Brasseur L (1999) Evolution of the French public's knowledge and attitudes regarding postoperative pain. Anesth Analg 89(3):659–664CrossRefPubMed
17.
go back to reference Colak D, Oguz A, Yazilitas D, Goksen Imamoglu I, Altinbas M (2014) Morphine: patient knowledge and attitudes in the central anatolia part of Turkey. Asian Pacific J Cancer Prev 15(12):4983–4988CrossRef Colak D, Oguz A, Yazilitas D, Goksen Imamoglu I, Altinbas M (2014) Morphine: patient knowledge and attitudes in the central anatolia part of Turkey. Asian Pacific J Cancer Prev 15(12):4983–4988CrossRef
18.
go back to reference Grant M, Ugalde A, Vafiadis P, Philip J (2015) Exploring the myths of morphine in cancer: views of the general practice population. Support Care Cancer 23(2):483–489CrossRefPubMed Grant M, Ugalde A, Vafiadis P, Philip J (2015) Exploring the myths of morphine in cancer: views of the general practice population. Support Care Cancer 23(2):483–489CrossRefPubMed
19.
go back to reference Peretti-Watel P, Bendiane MK, Galinier A, Lapiana JM, Favre R, Pegliasco V, Obadia Y, the south-eastern France palliative care group (2004) Opinions toward pain management and palliative care: comparison between HIV specialists and oncologists. AIDS Care 16(5):619–627CrossRefPubMed Peretti-Watel P, Bendiane MK, Galinier A, Lapiana JM, Favre R, Pegliasco V, Obadia Y, the south-eastern France palliative care group (2004) Opinions toward pain management and palliative care: comparison between HIV specialists and oncologists. AIDS Care 16(5):619–627CrossRefPubMed
20.
go back to reference Mazoyer J, Munoz Sastre MT, Sorum PC, Mullet E (2016) French laypeople’s and health professionals’ views on the acceptability of terminal sedation. J Med Ethics 42:627–631CrossRefPubMed Mazoyer J, Munoz Sastre MT, Sorum PC, Mullet E (2016) French laypeople’s and health professionals’ views on the acceptability of terminal sedation. J Med Ethics 42:627–631CrossRefPubMed
21.
go back to reference Fishman SM, Young HM, Arwood EL et al (2013) Core competencies for pain management: results of an interprofessional consensus summit. Pain Med 14(7):971–981CrossRefPubMedPubMedCentral Fishman SM, Young HM, Arwood EL et al (2013) Core competencies for pain management: results of an interprofessional consensus summit. Pain Med 14(7):971–981CrossRefPubMedPubMedCentral
22.
go back to reference Anderson NH (2008) Unified social cognition. Psychology Press, New York Anderson NH (2008) Unified social cognition. Psychology Press, New York
23.
go back to reference Anderson NH (2013) Unified psychology based on three laws of information integration. Rev Gen Psychol 17(1):125–132CrossRef Anderson NH (2013) Unified psychology based on three laws of information integration. Rev Gen Psychol 17(1):125–132CrossRef
25.
go back to reference Hofmans J, Mullet E (2013) Towards unveiling individual differences in different stages of information processing: a clustering-based approach. Qual Quant 47(1):555–564CrossRef Hofmans J, Mullet E (2013) Towards unveiling individual differences in different stages of information processing: a clustering-based approach. Qual Quant 47(1):555–564CrossRef
26.
go back to reference Schepers J, Hofmans J (2009) TwoMP: a MATLAB graphical user interface for two-mode partitioning. Behav Res Meth 41(2):507–514CrossRef Schepers J, Hofmans J (2009) TwoMP: a MATLAB graphical user interface for two-mode partitioning. Behav Res Meth 41(2):507–514CrossRef
28.
go back to reference Kamble S, Ahmed R, Sorum PC, Mullet E (2014) The acceptability among young Hindus and Muslims of actively ending the lives of newborns with genetic defects. J Med Ethics 40(3):186–191CrossRefPubMed Kamble S, Ahmed R, Sorum PC, Mullet E (2014) The acceptability among young Hindus and Muslims of actively ending the lives of newborns with genetic defects. J Med Ethics 40(3):186–191CrossRefPubMed
29.
go back to reference Johnston Conover P, Searing DD, Crewe IM (2002) The deliberative potential of political discussion. Br J Polit Sci 32(1):21–62 Johnston Conover P, Searing DD, Crewe IM (2002) The deliberative potential of political discussion. Br J Polit Sci 32(1):21–62
Metadata
Title
Mapping French people and health professionals’ positions regarding the circumstances of morphine use to relieve cancer pain
Authors
Julie Mazoyer
Maria Teresa Muñoz Sastre
Paul Clay Sorum
Etienne Mullet
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 9/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3682-z

Other articles of this Issue 9/2017

Supportive Care in Cancer 9/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine